summary slide.png (100.5 kB)
Efficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated Monogenic Autoinflammatory Disorders: A Scoping Review
media
posted on 2021-04-13, 09:38 authored by Adis Journals on behalf of, Pedro Jesús Gómez Arias, Francisco Gómez-García, Jorge Hernández-Perada, Ana María Montilla-López, Juan Ruano, Esmerelda Parra-PeralboArticle full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.
